{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:51:20Z","timestamp":1793299880705,"version":"4.5.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The presence of islet autoantibodies and islet reactive T cells (T+) in adults with established type 2 diabetes (T2D) have been shown to identify those patients with more severe \u03b2-cell dysfunction. However, at what stage in the progression toward clinical T2D does islet autoimmunity emerge as an important component influencing \u03b2-cell dysfunction? In this ancillary study to the Restoring Insulin SEcretion (RISE) Study, we investigated the prevalence of and association with \u03b2-cell dysfunction of T+ and autoantibodies to the 65 kDa glutamic acid decarboxylase antigen (GADA) in obese pre-diabetes adults with impaired glucose tolerance (IGT) and recently diagnosed treatment na\u00efve (Ndx) T2D. We further investigated the effect of 12 months of RISE interventions (metformin or liraglutide plus metformin, or with 3 months of insulin glargine followed by 9 months of metformin or placebo) on islet autoimmune reactivity. We observed GADA(+) in 1.6% of NdxT2D and 4.6% of IGT at baseline, and in 1.6% of NdxT2D and 5.3% of IGT at 12 months, but no significant associations between GADA(+) and \u03b2-cell function. T(+) was observed in 50% of NdxT2D and 60.4% of IGT at baseline, and in 68.4% of NdxT2D and 83.9% of IGT at 12 months. T(+) NdxT2D were observed to have significantly higher fasting glucose (<jats:italic>p<\/jats:italic> = 0.004), and 2 h glucose (<jats:italic>p<\/jats:italic> = 0.0032), but significantly lower steady state C-peptide (sscpep, <jats:italic>p<\/jats:italic> = 0.007) compared to T(\u2212) NdxT2D. T(+) IGT participants demonstrated lower but not significant (<jats:italic>p<\/jats:italic> = 0.025) acute (first phase) C-peptide response to glucose (ACPRg) compared to T(\u2212) IGT. With metformin treatment, T(+) participants were observed to have a significantly lower Hemoglobin A1c (HbA1c, <jats:italic>p<\/jats:italic> = 0.002) and fasting C-peptide (<jats:italic>p<\/jats:italic> = 0.002) compared to T(\u2212), whereas T(+) treated with liraglutide + metformin had significantly lower sscpep (<jats:italic>p<\/jats:italic> = 0.010) compared to T(\u2212) participants. In the placebo group, T(+) participants demonstrated significantly lower ACPRg (<jats:italic>p<\/jats:italic> = 0.001) compared to T(\u2212) participants. In summary, T(+) were found in a large percentage of obese pre-diabetes adults with IGT and in recently diagnosed T2D. Moreover, T(+) were significantly correlated with treatment effects and \u03b2-cell dysfunction. Our results demonstrate that T(+) are an important component in T2D.<\/jats:p>","DOI":"10.3389\/fimmu.2021.640251","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T17:00:54Z","timestamp":1645030854000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Islet Autoimmunity in Adults With Impaired Glucose Tolerance and Recently Diagnosed, Treatment Na\u00efve Type 2 Diabetes in the Restoring Insulin SEcretion (RISE) Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Barbara M.","family":"Brooks-Worrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley H.","family":"Tjaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Palomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Utzschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silva","family":"Arslanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieren J.","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen J.","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Barengolts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry P.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The RISE Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1373\/clinchem.2010.148270","article-title":"Is diabetes mellitus a continuous spectrum?","volume":"57","author":"Brooks-Worrell","year":"2011","journal-title":"Clin Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/JCI94549","article-title":"Autoreactive T cells in type 1 diabetes","volume":"127","author":"Pugliese","year":"2017","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.2337\/dc19-0475","article-title":"Setting the Stage for islet autoimmunity in type 2 diabetes: obesity-associated chronic systemic inflammation and endoplasmic reticulum (ER) stress","volume":"42","author":"Brooks-Worrell","year":"2019","journal-title":"Diabetes Care."},{"key":"B4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000356747","article-title":"Autoimmune aspects of type 2 diabetes mellitus-A mini-review","volume":"60","author":"Itariu","year":"2014","journal-title":"Gerontology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/JLB.3MR0220-243R","article-title":"Autoimmune responses and inflammation in type 2 diabetes","volume":"107","author":"Prasad","year":"2020","journal-title":"J Leuko Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fendo.2019.00451","article-title":"Type 2 diabetes: how much of an autoimmune disease?","volume":"10","author":"de Candia","year":"2019","journal-title":"Front Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2013.12.003","article-title":"CD8 T cell reactivity to islet antigens is unique to type 1 while CD4 T cell reactivity exists in both type 1 and type 2 diabetes","volume":"50","author":"Sarikonda","year":"2014","journal-title":"J Autoimmunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7457269","article-title":"Role of adaptive and innate immunity in type 2 diabetes mellitus","volume":"7457269","author":"Zhou","year":"2018","journal-title":"J Diabetes Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"593075","DOI":"10.1155\/2015\/593075","article-title":"Adaptive immunity and antigen-specific activation in obesity-associated insulin resistance","volume":"2015","author":"Hui Yen Chng","year":"2015","journal-title":"Mediators Inflammation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"10","author":"Zatterale","year":"2020","journal-title":"Front Physiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.biopha.2018.02.103","article-title":"The potential pathogenic role of IL-17\/Th17 cells in both type 1 and type 2 diabetes mellitus","volume":"101","author":"Abdel-Moneim","year":"2018","journal-title":"Biomed Pharmacotherapy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1161\/ATVBAHA.114.304636","article-title":"T cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans","volume":"34","author":"McLaughlin","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molimm.2018.11.015","article-title":"A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders","volume":"105","author":"Kamali","year":"2019","journal-title":"Mol Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2018.09.005","article-title":"Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients","volume":"197","author":"Wang","year":"2018","journal-title":"Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00592-019-01391-w","article-title":"Clinical manifestation and islet \u03b2-cell function of a subtype of latent autoimmune diabetes in adults (LADA): positive for T cell responses in phenotypic type 2 diabetes","volume":"56","author":"Liang","year":"2019","journal-title":"Acta Diabetologica."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.2337\/db06-0552","article-title":"T cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe \u03b2-cell lesions in phenotypic type 2 diabetes","volume":"56","author":"Goel","year":"2007","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.2337\/dc14-0961","article-title":"Impact of islet autoimmunity on the progressive \u03b2-cell functional decline in type 2 diabetes","volume":"37","author":"Brooks-Worrell","year":"2014","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00125-013-3116-5","article-title":"Association of proinflammatory cytokines and islet resident leukocytes with islet dysfunction in type 2 diabetes","volume":"57","author":"Butcher","year":"2014","journal-title":"Diabetologia"},{"key":"B20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/cei.12012","article-title":"Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients","volume":"171","author":"Brooks-Worrell","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0143551","article-title":"Use of a high-density protein microarray to identify autoantibodies in subjects with type 2 diabetes mellitus and an HLA background associated with reduced insulin secretion","volume":"10","author":"Chang","year":"2015","journal-title":"PLoS ONE"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s00125-011-2122-8","article-title":"HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion","volume":"54","author":"Williams","year":"2011","journal-title":"Diabetologia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/dmrr.2720","article-title":"T-cell receptor repertoire variation may be associated with type 2 diabetes mellitus in humans","volume":"32","author":"Frankl","year":"2016","journal-title":"Diabet Metabol Res Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"17248","DOI":"10.3389\/fimmu.2019.01198","article-title":"Autoreactive T cells in inflammatory skin diseases","volume":"10","author":"Boehncke","year":"2019","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.4049\/jimmunol.1002615","article-title":"Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes","volume":"186","author":"Jagannathan-Bogdan","year":"2011","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.2337\/db11-0090","article-title":"Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes","volume":"60","author":"Ferraro","year":"2011","journal-title":"Diabetes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.2337\/diabetes.54.5.1407","article-title":"Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes","volume":"54","author":"Brusko","year":"2005","journal-title":"Diabetes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2337\/dc13-1879","article-title":"Restoring insulin secretion (RISE): design of studies of \u03b2-cell preservation in prediabetes and early type 2 diabetes across the life span","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.2337\/db05-1378","article-title":"Analysis of T-cell assays to measure autoimmune responses in participants with type 1 diabetes: results of a blinded controlled study","volume":"55","author":"Seyfert-Margolis","year":"2006","journal-title":"Diabetes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.2337\/db09-0249","article-title":"Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes","volume":"58","author":"Herold","year":"2009","journal-title":"Diabetes"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.2337\/dc18-0243","article-title":"Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: II. Observations using the oral glucose tolerance test","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.2337\/dc18-0244","article-title":"Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: I. Observations using the hyperglycemic clamp","volume":"41","year":"2018","journal-title":"Diabetes Care."},{"key":"B34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1464-5491.1994.tb00273.x","article-title":"Understanding oral glucose tolerance: comparison of glucose or insulin measuremets during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion","volume":"11","author":"Phillips","year":"1994","journal-title":"Diabet Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1172\/JCI105534","article-title":"Insulin seretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus","volume":"46","author":"Seltzer","year":"1967","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/dom.13005","article-title":"Review of methods for measuring beta-cell function: design considerations from the Restoring Insulin Secretion (RISE) Consortium","volume":"20","author":"Hannon","year":"2018","journal-title":"Diabet Obesity Metabol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2337\/diabetes.47.12.1857","article-title":"Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: combinatorial islet autoantibody workshop","volume":"47","author":"Verge","year":"1998","journal-title":"Diabetes"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.2337\/dc18-1069","article-title":"Individuals fulfilling criteria for type 2 diabetes rather than LADA display transient signs of autoimmunity preceding diagnosis with possible clinical implications: the HUNT study","volume":"41","author":"S\u00f8rgjerd","year":"2018","journal-title":"Diabetes Care"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1007\/s00125-017-4403-3","article-title":"Relapsing\/remitting type 1 diabetes","volume":"60","author":"Van Megan","year":"2017","journal-title":"Diabetologia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35021081","article-title":"Progression of autoimmune diabetes driven by avidity maturation of a T -cell population","volume":"406","author":"Amrani","year":"2000","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nri2192","article-title":"type 1 diabetes as a relapsing-remitting disease?","volume":"7","author":"von Herrath","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s00125-012-2463-y","article-title":"Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway","volume":"55","author":"S\u00f8rgjerd","year":"2012","journal-title":"Diabetologia"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e3055","DOI":"10.1002\/dmrr.3055","article-title":"Evidence of diabetes-specific autoimmunity in obese subjects with normal glucose tolerance","volume":"34","author":"Tiberti","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5114\/ceji.2020.94670","article-title":"Th17 and regulatory T cells in patients with different time of progession of type 2 diabetes mellitus","volume":"45","author":"Guzman-Flores","year":"2020","journal-title":"Centr Eur J Immuol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2478\/rjim-2019-0003","article-title":"Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes","volume":"57","author":"Savchenko","year":"2019","journal-title":"Rom J Intern Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.2337\/db19-0299","article-title":"Effects of treatment of impaired glucose tolerance or recently diagnosed type 2 diabetes with metformin alone or in combination with insulin glargine on \u03b2-cell function: comparison of responses in youth and adults","volume":"68","year":"2019","journal-title":"Diabetes"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1210\/jc.2003-031360","article-title":"Autoimmunity to islet proteins in children diagnosed with new-onset diabetes","volume":"89","author":"Brooks-Worrell","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3390\/ijms20071632","article-title":"Age-associated changes in the immune system and blood-brain barrier functions","volume":"20","author":"Erickson","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.640251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T17:00:57Z","timestamp":1645030857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.640251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2021.640251"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.640251","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"article-number":"640251"}}